𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Inhibitors of cyclin-dependent kinase and cancer

✍ Scribed by J. R. Biggs; A. S. Kraft


Publisher
Springer
Year
1995
Tongue
English
Weight
621 KB
Volume
73
Category
Article
ISSN
0946-2716

No coin nor oath required. For personal study only.

✦ Synopsis


Recent research has yielded a dramatic increase in the number of connections between oncogenesis and the proteins which regulate the cell cycle. Three classes of protein which inhibit the activity of cyclin-dependent kinases (CDKs) have emerged as potential targets for oncogenic inactivation. p16 and related proteins inhibit the cyclin/CDK complexes which regulate the transition from G1 to S phase; numerous studies have revealed that p16 is mutated in most tumor cell lines and in some types of primary tumor. p21/WAF1/Cip 1 and the related p27Kip protein inhibit a broader range of cyclin/CDK complexes than p16. Although the absence of p21/WAF1/Cip1 from cyclin/CDK complexes is correlated with cellular transformation, no mutations in this gene have been found in tumors or tumor-derived cell lines. A third class of genes which are potential targets for oncogenic inactivation are the kinases and phosphatases which regulate the activity of cyclin/CDK complexes by phosphorylation and dephosphorylation of the CDK proteins. Disruption of any of these genes would result in loss of normal regulation of cell growth.


πŸ“œ SIMILAR VOLUMES


Analysis of cyclin-dependent kinase inhi
✍ Nguyen, TuDung T.; Nguyen, Carvell T.; Gonzales, Felicidad A.; Nichols, Peter W. πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 430 KB πŸ‘ 2 views

## Background: Downregulation of genes which negatively control cell cycle progression represents a possible mechanism for prostate tumorigenesis. we examined the expression levels of the p16, p15, p14, and retinoblastoma-susceptibility (rb) genes in primary prostate cancers and human prostate canc

Reduced expression and altered subcellul
✍ Alessandro Sgambato; Carlo Ratto; Beatrice Faraglia; Marta Merico; Raffaele Ardi πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 139 KB πŸ‘ 2 views

The p27 Kip1 protein is a negative regulator of the cell cycle and a potential tumor suppressor gene. Reduced expression of the p27 Kip1 protein has been reported in several human tumors and has been associated with higher tumor grade and increased mortality in breast, lung, colon, prostate, bladder

Increased expression of cyclin-dependent
✍ Ying Dong; Michael D. Walsh; Michael A. McGuckin; Brian B. Gabrielli; Margaret C πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 French βš– 336 KB πŸ‘ 2 views

Paraffin sections from 190 epithelial ovarian tumours, including 159 malignant and 31 benign epithelial tumours, were analysed immunohistochemically for expression of cyclin-dependent kinase inhibitor 2 (CDKN2A) gene product p16 INK4A (p16). Most benign tumours showed no p16 expression in the tumour

Molecular analysis of a family of cyclin
✍ Norihiko Kawamata; Carl W. Miller; H. Phillip Koeffler πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 626 KB

## Abstract Cyclin and cyclin‐dependent kinase (a) complexes play important roles in modulating the cell cycle. The CDK inhibitors (a) inhibit the kinase activities of these complexes and block the cell cycle. The __p16__/multiple tumor suppressor (__MTS__) 1/inhibitor of CDK4 (__INK4__) a/__CDKN2_

Molecular analysis of the cyclin-depende
✍ Akihiko Gemma; Seiichi Takenoshita; Koichi Hagiwara; Aikou Okamoto; Elisa A. Spi πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 French βš– 660 KB

Cyclin-dependent kinillre-4 inhibitor genes (INK4) regulate the cell cycle and are candidate tumor-suppressor genes. To determine if alterations in the coding regions of the p18 and p l 9 genes, which are novel members of the INK4 family and if they correlate with the development of human cancer, 10

Cyclin-dependent kinase inhibitors for t
✍ Peter L. Toogood πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 242 KB

## Abstract Cyclin dependent kinases (Cdks) are essential enzymes for the control of cell cycle progression. Inhibitors of cyclin‐dependent kinases are anticipated to possess therapeutic utility against a wide variety of proliferative diseases, especially cancer. The field of published small molecu